Brokerages Set AdaptHealth Corp. (NASDAQ:AHCO) PT at $14.29

AdaptHealth Corp. (NASDAQ:AHCO) has been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $13.8571.

AHCO has been the topic of several research analyst reports. Robert W. Baird dropped their price objective on shares of AdaptHealth from $18.00 to $15.00 and set an “outperform” rating on the stock in a report on Monday. Jefferies Financial Group reiterated a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a research note on Monday, April 20th. Wall Street Zen upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Weiss Ratings reissued a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Finally, Royal Bank Of Canada boosted their price target on AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Monday, May 11th.

AdaptHealth Stock Performance

AHCO stock traded down $0.01 on Tuesday, reaching $10.27. 184,029 shares of the company were exchanged, compared to its average volume of 1,370,291. The firm has a market capitalization of $1.40 billion, a PE ratio of -16.57, a PEG ratio of 0.55 and a beta of 1.45. AdaptHealth has a 12 month low of $8.51 and a 12 month high of $13.43. The stock’s fifty day moving average price is $10.66 and its 200 day moving average price is $10.62. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71.

Insider Activity at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the sale, the insider owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.95% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Rockefeller Capital Management L.P. increased its holdings in AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after buying an additional 2,100 shares during the period. FNY Investment Advisers LLC acquired a new position in shares of AdaptHealth in the 3rd quarter valued at $35,000. PNC Financial Services Group Inc. lifted its holdings in shares of AdaptHealth by 22.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after acquiring an additional 1,279 shares during the period. Assetmark Inc. lifted its holdings in shares of AdaptHealth by 54.8% during the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after acquiring an additional 2,460 shares during the period. Finally, Tower Research Capital LLC TRC boosted its position in shares of AdaptHealth by 318.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.